Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep12999.pdf
Reference56 articles.
1. Gibbs, C. P., Jr., Weber, K. & Scarborough, M. T. Malignant bone tumors. Instr Course Lect 51, 413–28 (2002).
2. Collins, M. et al. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol 31, 2303–12 (2013).
3. Damron, T. A., Ward, W. G. & Stewart, A. Osteosarcoma, chondrosarcoma and Ewing’s sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res 459, 40–7 (2007).
4. Fuchs, B. & Pritchard, D. J. Etiology of osteosarcoma. Clin Orthop Relat Res 397, 40–52 (2002).
5. Cha, T. L. et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310, 306–10 (2005).
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Retinoids and EZH2 inhibitors cooperate to orchestrate cytotoxic effects on bladder cancer cells;2023-04-21
2. TGF-β1 suppresses de novo cholesterol biosynthesis in granulosa-lutein cells by down-regulating DHCR24 expression via the GSK-3β/EZH2/H3K27me3 signaling pathway;International Journal of Biological Macromolecules;2023-01
3. EZH2 promotes the progression of osteosarcoma through the activation of the AKT / GSK3β pathway;Clinical and Experimental Pharmacology and Physiology;2022-08-03
4. LINC00313 facilitates osteosarcoma carcinogenesis and metastasis through enhancing EZH2 mRNA stability and EZH2-mediated silence of PTEN expression;Cellular and Molecular Life Sciences;2022-06-25
5. Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis;Cancers;2022-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3